Sangeeta Bhatia
Sangeeta N Bhatia
Sangeeta Bhatia
Co-Founder, Amplifyer Bio
Co-Founder, Ropirio Therapeutics
Co-Founder, Matrisome Bio
Co-Founder, Port Therapeutics
Co-Founder, Glympse Bio (acquired by Sunbird Bio)
Full Professor, Massachusetts Institute of Technology
Co-Founder, Satellite Bio
Joined
July 2019
Names
,
Emails
****@mit.edu (Confirmed)
Personal Links
Career & Education History
Co-Founder
Amplifyer Bio (amplifyer.bio)
2023 – Present
Co-Founder
Ropirio Therapeutics (ropirio.com)
2023 – Present
Co-Founder
Matrisome Bio (matrisomebio.com)
2023 – Present
Co-Founder
Port Therapeutics (porttherapeutics.com)
2022 – Present
Co-Founder
Glympse Bio (acquired by Sunbird Bio) (sunbirdbio.com)
2015 – Present
Full Professor
Massachusetts Institute of Technology (mit.edu)
2005 – Present
Co-Founder
Satellite Bio (satellite.bio)
2020 – 2026
Co-Founder
BioIVT (bioivt.com)
2008 – 2018
Associate Professor
University of California, San Diego (ucsd.edu)
1999 – 2005
Advisors, Relations & Conflicts
Expertise
Publications
No publications